1. Home
  2. CURR vs ACOG Comparison

CURR vs ACOG Comparison

Compare CURR & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Currenc Group Inc. Ordinary Shares

CURR

Currenc Group Inc. Ordinary Shares

HOLD

Current Price

$2.08

Market Cap

112.6M

ML Signal

HOLD

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

HOLD

Current Price

$5.72

Market Cap

129.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CURR
ACOG
Founded
2013
2000
Country
Singapore
Canada
Employees
N/A
N/A
Industry
Business Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
112.6M
129.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CURR
ACOG
Price
$2.08
$5.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$3.50
$18.00
AVG Volume (30 Days)
203.9K
61.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$14.56
$132.35
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$3.75
52 Week High
$4.68
$10.88

Technical Indicators

Market Signals
Indicator
CURR
ACOG
Relative Strength Index (RSI) 60.76 56.40
Support Level $1.47 $5.11
Resistance Level $2.34 $6.72
Average True Range (ATR) 0.19 0.66
MACD 0.06 0.13
Stochastic Oscillator 74.69 88.54

Price Performance

Historical Comparison
CURR
ACOG

About CURR Currenc Group Inc. Ordinary Shares

Currenc Group Inc is a fintech pioneer dedicated to transforming financial services through artificial intelligence (AI). It empowers financial institutions with comprehensive AI solutions, including the SEAMLESS AI Call Centre and other AI-powered tools designed to reduce costs, increase efficiency, and boost customer satisfaction. The Company's digital remittance platform also enables e-wallets, remittance companies, and corporations to provide real-time, 24/7 payment services, advancing financial access across underserved communities. It generates the majority of its geographic revenue from Malaysia.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: